Lupin today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ...

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...

Authors and Disclosures. Regis P Kowalski Department of Ophthalmology, Charles T Campbell Ophthalmic Microbiology Laboratory, The Eye and Ear Institute, University of Pittsburgh Medical Center ...